Condition
Hernia, Diaphragmatic
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results80% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed4
Recruiting1
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04718168Not ApplicableRecruiting
GORE® ENFORM Biomaterial Product Study
NCT01029665CompletedPrimary
Early Childhood Follow-up of Congenital Diaphragmatic Hernia Survivors
NCT05591482CompletedPrimary
Postoperative Outcomes of Trans-abdominal Open Surgical Repair of Traumatic Diaphragmatic Hernias in Adults.
NCT02875860Phase 2Completed
'TOTAL' (Tracheal Occlusion To Accelerate Lung Growth) Trial
NCT00133679Phase 4TerminatedPrimary
Chronic Sildenafil for Severe Diaphragmatic Hernia
NCT00226044Phase 3Completed
Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
Showing all 6 trials